Home
About
Publications Trends
Recent Publications
Expert Search
Archive
tcga (the cancer genome atlas)
What types of data are available in TCGA?
TCGA has generated and compiled a wide array of data types, including:
Genomic
data: DNA sequencing, RNA sequencing, and copy number variations.
Epigenomic
data: DNA methylation profiles.
Transcriptomic
data: Gene expression levels.
Proteomic
data: Protein expression levels.
Clinical data: Patient demographics, treatment history, and survival outcomes.
Frequently asked queries:
Why was TCGA created?
What types of data are available in TCGA?
How is TCGA data used in cancer research?
What are some significant findings from TCGA?
What is the future of TCGA and its impact on cancer research?
What are the Advantages of Continuous Drug Delivery?
What Types of Data Can Be Exchanged Using FHIR API?
What Strategies Can Be Used to Break Bad News to Cancer Patients?
What Role Do Suppliers Play in Raw Material Quality?
How Are Split Dose Regimens Administered?
How are Cyclins Related to Cancer?
How Do Web Interfaces Support Cancer Patients?
Who Can File a Complaint?
How Are Cancer Research Studies Designed?
What is the Role of Yoga in Cancer Care?
How to Create a Healthcare Power of Attorney?
Why is Immunosuppressive Therapy Used in Cancer Treatment?
What are some applications of TCGA data in cancer research?
Why is it Used in Cancer Care?
How Do Medical Devices Help?
Top Searches
Brain Tumor
Breast cancer
cancer
Cancer Genomics
Chemotherapy
hepatocellular carcinoma
Lung Cancer
Nanotechnology
Non-Hodgkin’s Lymphoma
Radiation-Induced Malignancies
Follow Us
Facebook
Linkedin
Youtube
Instagram
Partnered Content Networks
Relevant Topics
4D Segmentation
Alopecia
Atlas-based Segmentation
Automated Segmentation
B-cell malignancies
biomarkers
Brain Tumor
Brain Tumor Segmentation
Breast cancer
cancer
Cancer Genome Atlas
Cancer genomics
Cancer treatment
CAR T-cell therapy
Carcinogenesis
cell adhesion
cell migration
chemotherapy
Chromatin remodeling genes
Chronic inflammation
CIAbimatoprost
Co-morbidity
Combination therapy
Copy number variations
cytokine release syndrome
Deep Learning
Diagnosis challenges
diffuse large B-cell lymphoma
DNA damage
docetaxel-cyclophosphamide
Drug delivery
epirubicin-cyclophosphamide
extracellular matrix
Fibrosis
Genetic alteration
Glioblastoma
Gold nanoparticles
Hepatocellular carcinoma
High Tumor
image-guided radiotherapy
Imaging Techniques
Immunosuppression
Immunotherapy
Integrative genomics
integrin inhibitors
Integrins
intensity-modulated radiation therapy
Keratinocyte
Lipid-based nanoparticles
liver cancer
long-term cancer risks
Lung cancer
Machine Learning
Magnetic Resonance Imaging
metastasis
methyltransferase
MRI
Multi-modal Imaging
Multidisciplinary care
Mutual exclusivity analysis
Nanoparticles
Nanotechnology
neoadjuvant radiotherapy
neurotoxicity
Next-generation sequencing
nnovative Biomarkers
Non-Hodgkin’s lymphoma
Novel Biomarkers for Brain Tumors
Novel Chemotherapy
Oncogenic transcription factors
oncological diseases
paclitaxel
Personalized medicine
Photobiomodulation therapy
Polymeric nanoparticles
portal vein tumor thrombus
Probabilistic Models
proton therapy
Radiation-induced malignancies
radiotherapy
refractory lymphoma
relapsed lymphoma
Risk factors
secondary cancer prevention
secondary cancers
Silver nanoparticles
stereotactic body radiation therapy
Targeted therapy
Tolerability
transarterial chemoembolization
Tuberculosis
tumor microenvironment
tumor progression
Voltage-gated sodium channels
Subscribe to our Newsletter
Stay updated with our latest news and offers related to Cancer.
Subscribe